MedTrace Logo

Effect of the Food Supplement TOTUM-070 on Lipid Metabolism

NCT06243484 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 180

Last updated 2024-07-01

No results posted yet for this study

Summary

This clinical trial is to confirm the effects of TOTUM-070, a mix of 5 plants extracts, consumed at the daily regimen of two times per day, on fasting blood LDL cholesterol concentrations in moderately hypercholesterolemic subjects after 12 weeks of consumption (V3).

Conditions

Interventions

DIETARY_SUPPLEMENT

TOTUM-070

12 weeks of TOTUM-070 supplementation with Placebo (blinded arms)

DIETARY_SUPPLEMENT

PLACEBO

8 capsules per day to consume orally in two intakes

Sponsors & Collaborators

  • Valbiotis

    lead INDUSTRY

Principal Investigators

  • Daniel Menzel, MD · Biotesys

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-10-04
Primary Completion
2025-01-31
Completion
2025-04-30

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06243484 on ClinicalTrials.gov